Copyright Reports & Markets. All rights reserved.

Global Crude Heparin Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Crude Heparin Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Pig Intestine Mucosa Heparin
    • 1.3.3 Bovine Heparin and Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Crude Heparin Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 UFH
    • 1.4.3 LMWH
  • 1.5 Global Crude Heparin Market Size & Forecast
    • 1.5.1 Global Crude Heparin Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Crude Heparin Sales Quantity (2021-2032)
    • 1.5.3 Global Crude Heparin Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Bioiberica
    • 2.1.1 Bioiberica Details
    • 2.1.2 Bioiberica Major Business
    • 2.1.3 Bioiberica Crude Heparin Product and Services
    • 2.1.4 Bioiberica Crude Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Bioiberica Recent Developments/Updates
  • 2.2 Shenzhen Hepalink
    • 2.2.1 Shenzhen Hepalink Details
    • 2.2.2 Shenzhen Hepalink Major Business
    • 2.2.3 Shenzhen Hepalink Crude Heparin Product and Services
    • 2.2.4 Shenzhen Hepalink Crude Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Shenzhen Hepalink Recent Developments/Updates
  • 2.3 Sanofi
    • 2.3.1 Sanofi Details
    • 2.3.2 Sanofi Major Business
    • 2.3.3 Sanofi Crude Heparin Product and Services
    • 2.3.4 Sanofi Crude Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Sanofi Recent Developments/Updates
  • 2.4 Nanjing King-friend
    • 2.4.1 Nanjing King-friend Details
    • 2.4.2 Nanjing King-friend Major Business
    • 2.4.3 Nanjing King-friend Crude Heparin Product and Services
    • 2.4.4 Nanjing King-friend Crude Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Nanjing King-friend Recent Developments/Updates
  • 2.5 Fengrun Biological Technology
    • 2.5.1 Fengrun Biological Technology Details
    • 2.5.2 Fengrun Biological Technology Major Business
    • 2.5.3 Fengrun Biological Technology Crude Heparin Product and Services
    • 2.5.4 Fengrun Biological Technology Crude Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Fengrun Biological Technology Recent Developments/Updates
  • 2.6 Aspen Oss
    • 2.6.1 Aspen Oss Details
    • 2.6.2 Aspen Oss Major Business
    • 2.6.3 Aspen Oss Crude Heparin Product and Services
    • 2.6.4 Aspen Oss Crude Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Aspen Oss Recent Developments/Updates
  • 2.7 Hebei Changshan Biochemical
    • 2.7.1 Hebei Changshan Biochemical Details
    • 2.7.2 Hebei Changshan Biochemical Major Business
    • 2.7.3 Hebei Changshan Biochemical Crude Heparin Product and Services
    • 2.7.4 Hebei Changshan Biochemical Crude Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Hebei Changshan Biochemical Recent Developments/Updates
  • 2.8 Changzhou Qianhong
    • 2.8.1 Changzhou Qianhong Details
    • 2.8.2 Changzhou Qianhong Major Business
    • 2.8.3 Changzhou Qianhong Crude Heparin Product and Services
    • 2.8.4 Changzhou Qianhong Crude Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Changzhou Qianhong Recent Developments/Updates
  • 2.9 Hepac (Darling Ingredients)
    • 2.9.1 Hepac (Darling Ingredients) Details
    • 2.9.2 Hepac (Darling Ingredients) Major Business
    • 2.9.3 Hepac (Darling Ingredients) Crude Heparin Product and Services
    • 2.9.4 Hepac (Darling Ingredients) Crude Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Hepac (Darling Ingredients) Recent Developments/Updates
  • 2.10 Huaian MDC Pharmaceutical
    • 2.10.1 Huaian MDC Pharmaceutical Details
    • 2.10.2 Huaian MDC Pharmaceutical Major Business
    • 2.10.3 Huaian MDC Pharmaceutical Crude Heparin Product and Services
    • 2.10.4 Huaian MDC Pharmaceutical Crude Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Huaian MDC Pharmaceutical Recent Developments/Updates
  • 2.11 Yantai Dongcheng Biochemicals
    • 2.11.1 Yantai Dongcheng Biochemicals Details
    • 2.11.2 Yantai Dongcheng Biochemicals Major Business
    • 2.11.3 Yantai Dongcheng Biochemicals Crude Heparin Product and Services
    • 2.11.4 Yantai Dongcheng Biochemicals Crude Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Yantai Dongcheng Biochemicals Recent Developments/Updates

3 Competitive Environment: Crude Heparin by Manufacturer

  • 3.1 Global Crude Heparin Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Crude Heparin Revenue by Manufacturer (2021-2026)
  • 3.3 Global Crude Heparin Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Crude Heparin by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Crude Heparin Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Crude Heparin Manufacturer Market Share in 2025
  • 3.5 Crude Heparin Market: Overall Company Footprint Analysis
    • 3.5.1 Crude Heparin Market: Region Footprint
    • 3.5.2 Crude Heparin Market: Company Product Type Footprint
    • 3.5.3 Crude Heparin Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Crude Heparin Market Size by Region
    • 4.1.1 Global Crude Heparin Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Crude Heparin Consumption Value by Region (2021-2032)
    • 4.1.3 Global Crude Heparin Average Price by Region (2021-2032)
  • 4.2 North America Crude Heparin Consumption Value (2021-2032)
  • 4.3 Europe Crude Heparin Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Crude Heparin Consumption Value (2021-2032)
  • 4.5 South America Crude Heparin Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Crude Heparin Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Crude Heparin Sales Quantity by Type (2021-2032)
  • 5.2 Global Crude Heparin Consumption Value by Type (2021-2032)
  • 5.3 Global Crude Heparin Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Crude Heparin Sales Quantity by Application (2021-2032)
  • 6.2 Global Crude Heparin Consumption Value by Application (2021-2032)
  • 6.3 Global Crude Heparin Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Crude Heparin Sales Quantity by Type (2021-2032)
  • 7.2 North America Crude Heparin Sales Quantity by Application (2021-2032)
  • 7.3 North America Crude Heparin Market Size by Country
    • 7.3.1 North America Crude Heparin Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Crude Heparin Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Crude Heparin Sales Quantity by Type (2021-2032)
  • 8.2 Europe Crude Heparin Sales Quantity by Application (2021-2032)
  • 8.3 Europe Crude Heparin Market Size by Country
    • 8.3.1 Europe Crude Heparin Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Crude Heparin Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Crude Heparin Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Crude Heparin Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Crude Heparin Market Size by Region
    • 9.3.1 Asia-Pacific Crude Heparin Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Crude Heparin Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Crude Heparin Sales Quantity by Type (2021-2032)
  • 10.2 South America Crude Heparin Sales Quantity by Application (2021-2032)
  • 10.3 South America Crude Heparin Market Size by Country
    • 10.3.1 South America Crude Heparin Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Crude Heparin Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Crude Heparin Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Crude Heparin Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Crude Heparin Market Size by Country
    • 11.3.1 Middle East & Africa Crude Heparin Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Crude Heparin Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Crude Heparin Market Drivers
  • 12.2 Crude Heparin Market Restraints
  • 12.3 Crude Heparin Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Crude Heparin and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Crude Heparin
  • 13.3 Crude Heparin Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Crude Heparin Typical Distributors
  • 14.3 Crude Heparin Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Crude Heparin market size was valued at US$ 3919 million in 2025 and is forecast to a readjusted size of US$ 5504 million by 2032 with a CAGR of 5.0% during review period.
    Global key players of crude heparin include Bioiberica, Shenzhen Hepalink, Sanofi, Nanjing King-friend and Hebei Changshan Biochemical. The top five players hold a share about 46%. China is the largest market, which has a share about 56%, followed by North America and Europe, with share 19% and 18%, separately. In terms of product type, Pig Intestine Mucosa Heparin plays an important role with a share over 99%. In terms of application, LMWH holds an important share, with a share of 91%.
    This report is a detailed and comprehensive analysis for global Crude Heparin market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Crude Heparin market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Kg), 2021-2032
    Global Crude Heparin market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Kg), 2021-2032
    Global Crude Heparin market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Kg), 2021-2032
    Global Crude Heparin market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Kg), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Crude Heparin
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Crude Heparin market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bioiberica, Shenzhen Hepalink, Sanofi, Nanjing King-friend, Fengrun Biological Technology, Aspen Oss, Hebei Changshan Biochemical, Changzhou Qianhong, Hepac (Darling Ingredients), Huaian MDC Pharmaceutical, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Crude Heparin market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Pig Intestine Mucosa Heparin
    Bovine Heparin and Others
    Market segment by Application
    UFH
    LMWH
    Major players covered
    Bioiberica
    Shenzhen Hepalink
    Sanofi
    Nanjing King-friend
    Fengrun Biological Technology
    Aspen Oss
    Hebei Changshan Biochemical
    Changzhou Qianhong
    Hepac (Darling Ingredients)
    Huaian MDC Pharmaceutical
    Yantai Dongcheng Biochemicals
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Crude Heparin product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Crude Heparin, with price, sales quantity, revenue, and global market share of Crude Heparin from 2021 to 2026.
    Chapter 3, the Crude Heparin competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Crude Heparin breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Crude Heparin market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Crude Heparin.
    Chapter 14 and 15, to describe Crude Heparin sales channel, distributors, customers, research findings and conclusion.

    Buy now